𝔖 Bobbio Scriptorium

✦ LIBER ✦

A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris

✍ Scribed by Marc S Sabatine; James L Januzzi; Stephen Snapinn; Pierre Théroux; Ik-Kyung Jang

Book ID: 113974963
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 221 KB
Volume: 88
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(01)01724-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding Risk and Outcomes of Bivalirudi

Bleeding Risk and Outcomes of Bivalirudin Versus Glycoprotein IIb/IIIa Inhibitors With Targeted Low-Dose Unfractionated Heparin in Patients Having Percutaneous Coronary Intervention for Either Stable or Unstable Angina Pectoris

✍ Daniel H. Steinberg; Palak Shah; Tim Kinnaird; Tina L. Pinto Slottow; Probal K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Changes in glycoprotein IIb/IIIa inhibit

Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative

✍ Daniel W. Mudrick; Anita Y. Chen; Matthew T. Roe; L. Kristin Newby; W. Brian Gib 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Review finds early invasive therapy may

Review finds early invasive therapy may improve outcomes in unstable angina and non-ST-segment elevation myocardial infarction: Abstracted from: Bavry AA, Kumbhani DJ, Quiroz R, et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 2004; 93: 830–5.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB